Trial intelligence / Profile preview

Integrating Financial Coaching and Smoking Cessation Coaching for People With Low Income Who Smoke

NCT05154669Phase 3Recruiting

Sponsor
NYU Langone Health
Start
Dec 2022
Primary completion
Dec 2029
Countries
1
01

Overview

Phase 3, randomised, open-label trial in Tobacco Use Disorder (TUD) (2 arms), sponsored by NYU Langone Health. Primary endpoints: Effectiveness of the integrated intervention to standard cessation counseling on long-term abstinence (salivary cotinine) at 12 months and Effectiveness of the integrated intervention to standard cessation counseling on long-term abstinence (CO concentration) at 12 months. Started Dec 2022; status: recruiting.

02

Conditions

Tobacco Use Disorder (TUD)

Beyond the preview

Go deeper on NCT05154669.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05154669.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call